Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...

Medical device manufacturer Medtronic (NYSE: MDT) is a healthcare industry stalwart. The company, based in the U.S. and ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Medtronic’s (NYSE: MDT) growth efforts and investments in medical technology innovation are starting to pay off. The ...

Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...

Medtronic (NYSE:MDT – Get Free Report) had its target price raised by equities researchers at Robert W. Baird from $90.00 to $91.00 in a note issued to investors on Wednesday,Benzinga reports. The ...

As of 12/31/2024The holdings listed should not be considered recommendations to purchase or sell a particular security. Equity holdings are grouped to include common shares, depository receipts, ...

Discover the latest advancements in spine and orthopedic robotics, including the first biportal endoscopic fusion and FDA approval for Stryker.

Global healthcare technology developer Medtronic has launched the CD Horizon ModuLeX spinal system for deformity procedures, ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Based on China's accumulated rare disease knowledge and genetic data from its population, PUMCH-GENESIS is the world's first ...

The global Orthobiologics Market is valued at $6.56 billion in 2024 and is projected to reach a value of $10.4 billion by ...